Sep 11, 2018
Top Pharma News of the Week - September 10th
Top Pharma News of the Week – September 10th
All The Most Important Pharmaceutical News Stories Of The Week – September 2018 – Week # 2 Cablivi™ (caplacizumab) approved in Europe for adults with acquired thrombotic thrombocytopenic purpura (aTTP)
September 3, 2018
The European Commission has granted marketing authorization for Cablivi™ (caplacizumab) for the treatment of adults experiencing an episode of acquired thrombotic thrombocytopenic…
View On WordPress